3 wins for Regeneron: Phase 3 trial success vs allergies
Regeneron’s itepekimab antibody treatment posts 3 wins in Phase 3 trials, showing significant improvement against both cat allergies and seasonal pollen allergies.
allergy
Read More
February 8, 2026